Atorvastatin prevents development of kindling by modulating hippocampal levels of dopamine, glutamate, and GABA in mice
Published Jan 31, 2015 · Nouroz Sehar, N. Agarwal, D. Vohora
Epilepsy & Behavior
38
Citations
1
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayAtorvastatin suppresses the development of PTZ kindling in mice by altering redox status and hippocampal levels of dopamine, glutamate, and GABA.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.